These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9790085)

  • 21. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
    Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
    Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N; Zittermann A; Koertke H; Maleszka A; Knobl H; Coskun T; Kleesiek K; Koerfer R
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental evaluation of a heparin coated ECMO system simplified with a centrifugal pump.
    Matsuwaka R; Matsuda H; Kaneko M; Miyamoto Y; Sakagoshi N; Kuratani T; Chang JC; Kawashima Y; Hagiwara K; Fukazawa H
    ASAIO Trans; 1990; 36(3):M473-5. PubMed ID: 2123638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hollow fiber and spiral coil membrane oxygenators designed for cardiopulmonary bypass in infants.
    Rawitscher RE; Dutton RC; Edmunds LH
    Circulation; 1973 Jul; 48(1 Suppl):III105-11. PubMed ID: 4198469
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal.
    Murphy JA; Savage CM; Alpard SK; Deyo DJ; Jayroe JB; Zwischenberger JB
    Perfusion; 2001 Nov; 16(6):460-8. PubMed ID: 11761085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuit.
    van der Hulst VP; Henny CP; Moulijn AC; Engbers G; ten Cate H; Gründeman PF; Klopper PJ
    J Cardiovasc Surg (Torino); 1989; 30(1):118-23. PubMed ID: 2925769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.
    Ranucci M; Cazzaniga A; Soro G; Isgrò G; Frigiola A; Menicanti L
    J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):316-20. PubMed ID: 12073203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a membrane oxygenator for long-term respiratory support and its experimental evaluation in prolonged ECMO.
    Eya K; Tatsumi E; Taenaka Y; Takewa Y; Wakisaka Y; Toda K; Nakatani T; Masuzawa T; Baba Y; Miyazaki K; Nishimura T; Ohno T; Ahn JM; Takano H; Mimura R; Tanaka S; Wada T
    ASAIO J; 1996; 42(5):M832-6. PubMed ID: 8945000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin free long-term extracorporeal circulation using bioactive surfaces.
    Mottaghy K; Oedekoven B; Pöppel K; Bruchmüller K; Kovacs B; Spahn A; Geisen C
    ASAIO Trans; 1989; 35(3):635-7. PubMed ID: 2512973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS.
    Bindslev L; Böhm C; Jolin A; Hambraeus Jonzon K; Olsson P; Ryniak S
    Acta Anaesthesiol Scand Suppl; 1991; 95():125-30; discussion 130-1. PubMed ID: 1927222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-coated versus non-coated surfaces for extracorporeal circulation.
    Mottaghy K; Oedekoven B; Pöppel K; Kovacs B; Kirschfink M; Bruchmüller K; Kashefi A; Geisen C
    Int J Artif Organs; 1991 Nov; 14(11):721-8. PubMed ID: 1757160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of surfaces with end point attached heparin to extracorporeal circulation with membrane lungs.
    Mottaghy K; Oedekoven B; Schaich-Lester D; Pöppel K; Küpper W
    ASAIO Trans; 1989; 35(2):146-52. PubMed ID: 2730814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total and prolonged filling of the lungs with Ringer's solution under extracorporeal lung assist (ECLA) in dogs.
    Sakanashi Y; Tanimoto H; Okamoto T; Tashiro M; Ao H; Terasaki H
    Acta Anaesthesiol Scand; 2000 Sep; 44(8):994-1001. PubMed ID: 10981579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.